DEFA14A: Nauticus Robotics Seeks Massive Share Authorization Increase

Nauticus Robotics, Inc. will ask shareholders to approve an amendment to increase its authorized common stock from 625 million to 5 billion shares at a special meeting on November 21, 2025.

Summary

• Nauticus Robotics, Inc. (the Company) has added Proposal 3 to its Special Meeting agenda for November 21, 2025.
• Proposal 3 seeks shareholder approval to amend the Company's Second Amended and Restated Certificate of Incorporation to increase the number of authorized Common Stock from 625,000,000 to 5,000,000,000 shares.
• As of October 24, 2025, 6,848,891 shares of Common Stock were issued, with additional shares reserved for warrants (60,602), convertible term loans (630,225), convertible debentures (230,662), convertible preferred equity (2,308,536), stock options (1,880), and future equity incentive plan awards (143,133).
• The proposed amendment would provide an additional 4,375,000,000 authorized shares of Common Stock, bringing the total authorized capital stock to 5,010,000,000 (5,000,000,000 Common Stock and 10,000,000 Preferred Stock).
• The Board of Directors recommends a vote FOR Proposal 3, requiring the affirmative vote of a majority of outstanding Common Stock, with abstentions counting as a vote against.

Sentiment

Score: 7

Explanation: The filing indicates a proactive step by management to ensure long-term financial and strategic flexibility, which is generally positive for a company's future growth prospects, despite the inherent potential for shareholder dilution.

Positives

• Provides the Company with significant flexibility for future corporate needs without requiring additional shareholder approval for each issuance (subject to law and Nasdaq rules).
• Enables the Company to raise capital through offerings of Common Stock or convertible securities, if appropriate opportunities arise.
• Allows for the provision of equity incentives to employees, officers, directors, customers, consultants, or advisors, which can aid in talent retention and motivation.
• Facilitates potential expansion of the Company's business through acquisitions of other businesses or assets.
• Supports potential stock splits, dividends, and similar transactions, as well as debt or equity restructuring or refinancing transactions.

Negatives

• Future issuance of Common Stock or convertible securities could have a dilutive effect on the earnings per share, book value per share, voting power, and percentage interest of current stockholders.
• The availability of a large number of additional shares for issuance could, under certain circumstances, discourage or make more difficult efforts to obtain control of the Company in a takeover scenario, even if not the Board's intent.

Risks

• Potential for significant dilution of current stockholders' equity, voting power, and earnings per share if a substantial number of the newly authorized shares are issued.
• While not intended as an anti-takeover measure, the increased authorized shares could make hostile takeovers more challenging, potentially limiting shareholder options in such scenarios.

Future Outlook

The Company anticipates using the additional authorized shares for various future corporate needs, including raising capital, providing equity incentives, expanding through acquisitions, facilitating stock splits, and supporting debt or equity restructuring. This move is intended to provide greater flexibility to the Board in considering and planning for potential future corporate needs.

Management Comments

• "After careful consideration, the Board has adopted, declared advisable and directed that there be submitted to the stockholders at the Special Meeting a proposed amendment... to increase the number of shares of authorized Common Stock from 625,000,000 to 5,000,000,000."
• "The Board has not proposed the increase in the number of authorized shares of Common Stock with the intent of preventing or discouraging any actual or threatened tender offers or takeover attempts of the Company and the Board is not currently aware of any attempt or plan to acquire control of the Company."
• "THE BOARD RECOMMENDS A VOTE FOR THE PROPOSAL TO APPROVE AN AMENDMENT TO OUR SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK FROM 625,000,000 to 5,000,000,000 SHARES."

Industry Context

Increasing authorized share capital is a common strategic move for companies, particularly those in growth-oriented or capital-intensive sectors like robotics, to ensure sufficient flexibility for future financing, strategic partnerships, and employee incentive programs. This action aligns with a broader trend of companies seeking to maintain agility in dynamic market environments.

Comparison to Industry Standards

• This filing primarily addresses a corporate governance matter regarding authorized share capital and does not contain specific operational or financial performance data that would allow for a direct comparison to industry-specific benchmarks or competitor results.
• The decision to increase authorized shares is a strategic move common across various industries for companies seeking future financial and operational flexibility, similar to actions taken by other technology or growth companies preparing for potential capital raises or M&A activities.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for dilution of earnings per share, book value per share, voting power, and percentage interest of holdings if additional shares are issued.
• Employees, Officers, Directors, Customers, Consultants, or Advisors: Potential to receive equity incentives, which could enhance motivation and alignment with company goals.

Next Steps

• Shareholders will vote on Proposal 3 at the Special Meeting on November 21, 2025.
• If approved, the Authorized Shares Amendment will become effective upon filing a Certificate of Amendment to the Certificate of Incorporation with the Delaware Secretary of State promptly after the Special Meeting.

Key Dates

Keywords

Nauticus Robotics, authorized shares, common stock, proxy statement, capital raise, dilution, corporate governance, shareholder meeting, equity incentives, acquisitions